Interaction between dipeptidyl-peptidase-4 inhibitors and drugs acting on renin angiotensin aldosterone system for the risk of angioedema: a pharmacovigilance assessment using disproportionality and interaction analyses

Interaction between dipeptidyl-peptidase-4 inhibitors and drugs acting on renin angiotensin aldosterone system for the risk of angioedema: a pharmacovigilance assessment using disproportionality and interaction analyses

Abstract Background Dipeptidyl peptidase-4 inhibitors (DPP-4is) and drugs interfering with the renin-angiotensin-aldosterone system (RAAS) are frequently co-prescribed in type 2 diabetes management. Both drug classes have been independently associated with angioedema, raising concerns about potentia...

Full description

Bibliographic Details
Main Authors: Kannan Sridharan, Gowri Sivaramakrishnan
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Sitagliptin
Saxagliptin
Alogliptin
Lisinopril
Valsartan
Irbesartan
Online Access:https://doi.org/10.1186/s13098-024-01570-y

Internet

https://doi.org/10.1186/s13098-024-01570-y

Similar Items